Participants in the 23andMe Parkinson’s disease research initiative have contributed a vast amount of data, that has enabled our researchers and collaborators to improve our understanding of the genetics of...

Scientists at 23andMe and Genentech have identified 17 new genetic variants associated with Parkinson’s disease, almost doubling the total number of known risk variants for the condition, which gives scientists hints at potential new targets for drugs to treat the disease.

23andMe Parkinson's disease researchers plan to collect new types of data for their work.

April is Parkinson’s Awareness Month and this year it also marks the eighth anniversary of 23andMe’s Parkinson’s Research Community, which introduced a game-changing model for science, one that leverages online...

After four days in Berlin attending the massive annual meeting of the International Parkinson’s and Movement Disorders Society, 23andMe Parkinson’s Community manager, Paul Cannon, PhD, came back hopeful for the...

In his last fight– the one against Parkinson’s – Muhammad Ali went the distance finally succumbing in early June to complications from a respiratory problem.He was 74. In the more...

There are many faces of Parkinson’s, Claudia’s just happens to be smiling most of the time. “I’m an optimistic person,” said the mother of two teenage boys who lives with...

To mark Parkinson’s Awareness Month, we’re taking a moment to look at some of the accomplishments 23andMe has made in the study of the disease in a relatively short time....

In two recent reports , Parkinson’s researchers describe findings that may lead to new ways of detecting early signs of the disease and a potential new treatment. In the first...

As federal regulators listened, patients told them of their symptoms – the sleepless nights, the days with uncontrollable tremors or the little struggles simply maintaining their balance. Paul Cannon, 23andMe’s...